Vitamin Blue Stock Beta
| VTMB Stock | USD 0.0001 0.00 0.00% |
Vitamin Blue fundamentals help investors to digest information that contributes to Vitamin Blue's financial success or failures. It also enables traders to predict the movement of Vitamin Pink Sheet. The fundamental analysis module provides a way to measure Vitamin Blue's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vitamin Blue pink sheet.
Vitamin |
Vitamin Blue Company Beta Analysis
Vitamin Blue's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Vitamin Blue Beta | 48.49 |
Most of Vitamin Blue's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vitamin Blue is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Vitamin Blue has a Beta of 48.4948. This is much higher than that of the Consumer Cyclical sector and notably higher than that of the Leisure industry. The beta for all United States stocks is notably lower than that of the firm.
Vitamin Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vitamin Blue's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Vitamin Blue could also be used in its relative valuation, which is a method of valuing Vitamin Blue by comparing valuation metrics of similar companies.Vitamin Blue is currently under evaluation in beta category among related companies.
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Vitamin Blue will likely underperform.
Vitamin Fundamentals
| Return On Asset | -1.4 | |||
| Operating Margin | (0.78) % | |||
| Current Valuation | 766.89 K | |||
| Shares Outstanding | 783.4 M | |||
| Price To Earning | (0.40) X | |||
| Price To Sales | 4.82 X | |||
| Revenue | 250.03 K | |||
| Gross Profit | 55.5 K | |||
| EBITDA | (112.37 K) | |||
| Net Income | (21.08 K) | |||
| Cash And Equivalents | 2.52 K | |||
| Total Debt | 307.37 K | |||
| Current Ratio | 0.04 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | 7.69 K | |||
| Earnings Per Share | (0) X | |||
| Beta | 48.49 | |||
| Market Capitalization | 14.1 K | |||
| Total Asset | 31.72 K | |||
| Retained Earnings | (2.84 M) | |||
| Working Capital | (706 K) | |||
| Current Asset | 30 K | |||
| Current Liabilities | 736 K | |||
| Net Asset | 31.72 K |
About Vitamin Blue Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vitamin Blue's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vitamin Blue using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vitamin Blue based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vitamin Blue in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vitamin Blue's short interest history, or implied volatility extrapolated from Vitamin Blue options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vitamin Blue. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for Vitamin Pink Sheet analysis
When running Vitamin Blue's price analysis, check to measure Vitamin Blue's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vitamin Blue is operating at the current time. Most of Vitamin Blue's value examination focuses on studying past and present price action to predict the probability of Vitamin Blue's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vitamin Blue's price. Additionally, you may evaluate how the addition of Vitamin Blue to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| CEOs Directory Screen CEOs from public companies around the world |